French tweak national law to better comply with EU's IVD (in vitro diagnostic) Directive
This article was originally published in Clinica
The French health ministry has published a decree updating requirements for HIV tests in the light of the IVD Directive taking full effect on December 8 2003. The decree modifies an existing law, which is not in conformity with the IVD Directive since it requires that laboratories only use HIV tests that have been registered in France - a procedure involving heavy documentation requirements. It also requires that products must have passed specific national controls.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.